Massive Price/Volume Surge: AMAG PHARMA (AMAG)

Posted in General, pre-market 
November 13th, 2008

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is soaring pre-market and is one of the few winner sthis morning.  The FDA has designated its resubmission to the October 2008 Complete Response letter for its New Drug Application for ferumoxytol as a complete, and as a Class 1 response. AMAG is seeking marketing approval for ferumoxytol for the treatment of patients with iron deficiency anemia in all stages of chronic kidney disease.

At 9:09 AM EST we have seen 1.13 million shares trade and the stock is up OVER 75% at $32.64.  Shares were right at 52-week lows just yesterday and the 52-week trading range is $18.33 to $66.94.

Expectto see exponential stock and options volume today.  Average volume is only 665,000 shares.

Jon C. Ogg
November 13, 2008

Comments are closed